Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Erttmann

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Annals of Hematology|November 28, 2002
Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulinN Kröger, T Zabelina, H Renges, et al.
Leukemia & Lymphoma|February 1, 1997
Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantationW Krüger, M Stockschläder, I Sobottka, et al.
Klinische Padiatrie|May 1, 1983
[COALL-80 therapy in the management of acute lymphoblastic leukemia in childhood--an interim report]K Winkler, G Beron, R Erttmann, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
10 years' neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the Study Group for Evaluation of Neuroblastoma Screening in Europe (SENSE)R Erttmann, T Tafese, F Berthold, et al.
Bone Marrow Transplantation|July 23, 1998
Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapyN Kröger, M Hoffknecht, M Hänel, et al.
British Journal of Haematology|October 16, 1999
Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patientsM Dürken, M Horstmann, P Bieling, et al.
Bone Marrow Transplantation|June 3, 2008
EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCTS Ocheni, N Kroeger, T Zabelina, et al.
Bone Marrow Transplantation|April 27, 1999
Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 casesW Krüger, B Rüssmann, N Kröger, et al.
Bone Marrow Transplantation|August 16, 2002
In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donorsN Kröger, T Zabelina, W Krüger, et al.
Annals of Hematology|June 13, 2001
Anti-thymocyte-globulin as part of the preparative regimen prevents graft failure and severe graft versus host disease (GvHD) in allogeneic stem cell transplantation from unrelated donorsN Kröger, T Zabelina, W Krüger, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Annals of Hematology|November 28, 2002
Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulinN Kröger, T Zabelina, H Renges, et al.
Leukemia & Lymphoma|February 1, 1997
Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantationW Krüger, M Stockschläder, I Sobottka, et al.
Klinische Padiatrie|May 1, 1983
[COALL-80 therapy in the management of acute lymphoblastic leukemia in childhood--an interim report]K Winkler, G Beron, R Erttmann, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
10 years' neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the Study Group for Evaluation of Neuroblastoma Screening in Europe (SENSE)R Erttmann, T Tafese, F Berthold, et al.
Bone Marrow Transplantation|July 23, 1998
Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapyN Kröger, M Hoffknecht, M Hänel, et al.
British Journal of Haematology|October 16, 1999
Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patientsM Dürken, M Horstmann, P Bieling, et al.
Bone Marrow Transplantation|June 3, 2008
EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCTS Ocheni, N Kroeger, T Zabelina, et al.
Bone Marrow Transplantation|April 27, 1999
Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 casesW Krüger, B Rüssmann, N Kröger, et al.
Bone Marrow Transplantation|August 16, 2002
In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donorsN Kröger, T Zabelina, W Krüger, et al.
Annals of Hematology|June 13, 2001
Anti-thymocyte-globulin as part of the preparative regimen prevents graft failure and severe graft versus host disease (GvHD) in allogeneic stem cell transplantation from unrelated donorsN Kröger, T Zabelina, W Krüger, et al.
Pageof 9